Newark, NJ, June 24, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global macroencapsulation market is expected to grow from USD 17.38 billion in 2020 to USD 48.55 billion ...

Technology Will Enable Safe And Efficacious Delivery Of Pancryos' Stem Cell Derived Therapy For Treatment Of Type 1 Diabetes Visualization by Randal McKenzie COPENHAGEN, Denmark, May 24, 2022 ...

TOULOUSE, FRANCE — Pancreatic islet transplantation has been offered since 2020 in about 10 certified French centers, but its numerous limitations are compelling scientists to turn to cellular and ...

More than 40 million people worldwide are affected with type 1 diabetes (T1D) mellitus, an autoimmune disease in which insulin producing β-cells in the pancreas are destroyed by the immune system.

A team of researchers from Brigham and Women’s Hospital, Harvard University, and the University of Massachusetts Medical School has designed a convection-enhanced macroencapsulation device (ceMED) ...

GENEVA, June 27, 2024 (GLOBE NEWSWIRE) -- Release Therapeutics (‘Release Tx’ or ‘the Company’), a privately-held, Swiss BioMedTech company, announced today the appointment of Thomas Mehrling, MD, PhD, ...

Technology Will Enable Safe And Efficacious Delivery Of Pancryos' Stem Cell Derived Therapy For Treatment Of Type 1 Diabetes Visualization by Randal McKenzie "There are significant advantages of ceMED ...